These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 673092

  • 1. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.
    Beaufils H, Alphonse JC, Guedon J, Legrain M.
    Nephron; 1978; 21(2):75-85. PubMed ID: 673092
    [Abstract] [Full Text] [Related]

  • 2. [Effects of treatment with corticosteroids and indomethacin on proteinuria].
    Michielsen P, Lambert PP.
    J Urol Nephrol (Paris); 1967; 73(4):340-55. PubMed ID: 6066085
    [No Abstract] [Full Text] [Related]

  • 3. Drug treatment of the chronic idiopathic glomerulopathies.
    Lindeman RD.
    Postgrad Med; 1977 Sep; 62(3):135-43. PubMed ID: 302444
    [No Abstract] [Full Text] [Related]

  • 4. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response.
    Arbus GS, Poucell S, Bacheyie GS, Baumal R.
    J Pediatr; 1982 Jul; 101(1):40-5. PubMed ID: 7045316
    [Abstract] [Full Text] [Related]

  • 5. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Torres VE, Velosa JA, Holley KE, Frohnert PP, Zincke H, Sterioff S.
    Mayo Clin Proc; 1984 Mar; 59(3):146-52. PubMed ID: 6369011
    [Abstract] [Full Text] [Related]

  • 6. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.
    Walker RG, Kincaid-Smith P.
    Nephron; 1990 Mar; 54(2):117-21. PubMed ID: 2179754
    [Abstract] [Full Text] [Related]

  • 7. Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases.
    Mungan S, Turkmen E, Aydin MC, Saglam AE, Baydar DE.
    Ren Fail; 2015 Jun; 37(5):858-65. PubMed ID: 25857429
    [Abstract] [Full Text] [Related]

  • 8. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 9. [Idiopathic nephrotic syndrome in children: report of 57 cases].
    Ghedira-Besbes L, Mallek A, Guediche MN.
    Tunis Med; 2003 Sep; 81(9):702-8. PubMed ID: 17722782
    [Abstract] [Full Text] [Related]

  • 10. [Current trends in the treatment of primary glomerulonephritis].
    Ponticelli C, Passerini P.
    Minerva Urol Nefrol; 1984 Sep; 36(4 Suppl):7-13. PubMed ID: 6398922
    [No Abstract] [Full Text] [Related]

  • 11. Focal sclerosing glomerulonephritis.
    Habib R, Gubler MC.
    Perspect Nephrol Hypertens; 1973 Sep; 1 Pt 1():263-78. PubMed ID: 4536428
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH, Fisher M, Neale TJ.
    N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
    [Abstract] [Full Text] [Related]

  • 13. Indomethacin treatment of recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation.
    Kooijmans-Coutinho MF, Tegzess AM, Bruijn JA, Florijn KW, van Es LA, van der Woude FJ.
    Nephrol Dial Transplant; 1993 Mar 28; 8(5):469-73. PubMed ID: 8393556
    [No Abstract] [Full Text] [Related]

  • 14. [Corticosteroid therapy of compensated intracapillary glomerulonephritis].
    Ratner MIa, Tomilina NA, Samokhina NM.
    Klin Med (Mosk); 1982 Apr 28; 60(4):72-6. PubMed ID: 7098396
    [No Abstract] [Full Text] [Related]

  • 15. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
    Kidney Int; 2004 May 28; 65(5):1690-702. PubMed ID: 15086908
    [Abstract] [Full Text] [Related]

  • 16. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA.
    Nephron; 1987 May 28; 46(1):73-7. PubMed ID: 3600915
    [Abstract] [Full Text] [Related]

  • 17. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A, Dial C, Ka EF, Lèye A, Pouye A, Ka MM, Mbengue M, Droz D, Diouf B.
    Dakar Med; 2008 May 28; 53(1):45-51. PubMed ID: 19102117
    [Abstract] [Full Text] [Related]

  • 18. Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units.
    Stirling CM, Mathieson P, Boulton-Jones JM, Feehally J, Jayne D, Murray HM, Adu D.
    QJM; 2005 Jun 28; 98(6):443-9. PubMed ID: 15879445
    [Abstract] [Full Text] [Related]

  • 19. Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.
    Meyrier A.
    Springer Semin Immunopathol; 1987 Jun 28; 9(4):441-50. PubMed ID: 3324370
    [No Abstract] [Full Text] [Related]

  • 20. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF, Farine M, Thorner P, Baumal R.
    Clin Nephrol; 1984 Sep 28; 22(3):109-13. PubMed ID: 6488594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.